Secondly, due to the nature of the database, the study lacked some potential variables such as cytogenetic results, bone marrow pathology results, MM staging, and some important related laboratory results (such as beta-2 microglobulin, lactate dehydrogenase), and treatment information. This evidence concerns the gene B2M and Miyoshi myopathy.